The National Institutes of Health will award $3 million in grants to up to six recipients for research into medications that can be used to treat marijuana-related disorders.

The grants will "support research studies that focus on the identification, and preclinical and clinical evaluation of medications that can be safe and effective for the treatment of cannabis-use and -induced disorders, as well as their medical and psychiatric consequences."

Awards will be made under the R01 and R21 grant mechanisms. Nonprofits, for-profit companies, schools, government agencies, and others may apply.

Application deadline is Sept. 10. For more information, see the grant announcements online at the links above.